Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana Puertes"'
Autor:
Ana Puertes, Helin Polat, Luis Andrés Ramón-Núñez, Matilde González, Gema Ancillo, Elena Zuriaga, Gabino Ríos
Publikováno v:
Plants, Vol 12, Iss 14, p 2601 (2023)
Transcriptomic and gene expression analysis have greatly facilitated the identification and characterization of transcriptional regulatory factors and effectors involved in dormancy progression and other physiological processes orchestrated during bu
Externí odkaz:
https://doaj.org/article/5c5dee7d87634922b5b427991d097f3c
Autor:
Ríos, Ana Puertes, Helin Polat, Luis Andrés Ramón-Núñez, Matilde González, Gema Ancillo, Elena Zuriaga, Gabino
Publikováno v:
Plants; Volume 12; Issue 14; Pages: 2601
Transcriptomic and gene expression analysis have greatly facilitated the identification and characterization of transcriptional regulatory factors and effectors involved in dormancy progression and other physiological processes orchestrated during bu
Autor:
Luis de la Cruz-Merino, María Gion, Josefina Cruz, Jose Luis Alonso-Romero, Vanesa Quiroga, Fernando Moreno, Raquel Andrés, Marta Santisteban, Manuel Ramos, Esther Holgado, Javier Cortés, Elena López-Miranda, Alfonso Cortés, Fernando Henao, Natalia Palazón-Carrión, Luz Milva Rodriguez, Isaac Ceballos, Asunción Soto, Ana Puertes, Maribel Casas, Sara Benito, Massimo Chiesa, Susana Bezares, Rosalía Caballero, Carlos Jiménez-Cortegana, Víctor Sánchez-Margalet, Federico Rojo
Publikováno v:
Scientia
Background We evaluated a new chemoimmunotherapy combination based on the anti-PD1 monoclonal antibody pembrolizumab and the pyrimidine antimetabolite gemcitabine in HER2- advanced breast cancer (ABC) patients previously treated in the advanced setti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793cf9f98529cf4a459705fd313a4db6
https://doi.org/10.21203/rs.3.rs-1638137/v2
https://doi.org/10.21203/rs.3.rs-1638137/v2
Autor:
Ana Puertes Boix, Edith Rodriguez, Maria Del Rosario Garcia Hernandez, Jeronimo Martinez Garcia, Miguel Marin, Pilar Sanchez-Henarejos, Marta Guirao Maran, Miler Cuellar, Guadalupe Ruiz Merino, Silver Ros, Jose Luis Alonso Romero, Alicia Cano, David Collados, Rosario Salgado, MDolores Jimenez-Lucas, Asuncion Soto
Publikováno v:
Journal of Clinical Oncology. 35:5566-5566
5566 Background: Circulating free DNA (cfDNA) and circulating tumor cells (CTC) are new biomarkers for malignant tumors. Its role on ovarian epithelial cancer (OEC) is not yet well stablished. We analyze its role on advanced OEC compared with CA125 a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.